IP Library Granted Patent US 8,475,837
Granted Patent B2
US 8,475,837 · App. 12/952,516 · Granted Jul 2, 2013

Abuse potential reduction in abusable substance dosage form

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,475,837
App. No.
12/952,516
Granted
Jul 2, 2013
Kind
B2
Abstract

The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.

Claims (15)

1. A device comprising:

(a) an independent disposable container having an opening therein to receive a skin-worn patch device containing a residual amount of an abusable substance therein;

(b) a layer containing an amount of an anti-abuse substance comprising an adsorption material which is activated carbon that prevents solvent extraction of said abusable substance, said layer being disposed in said container in a manner such that a skin-worn patch device properly inserted into said container will cause said abusable substance to contact said layer containing said anti-abuse substance; and

(c) a closure means for closing said container containing a used skin-worn patch device.

2. The device according to claim 1 , wherein said anti-abuse substance further comprises an agent selected from the group consisting of co-soluble antagonists, irritants and combinations thereof.

3. The device according to claim 1 , wherein said solvent extraction employs a solvent selected from the group consisting of water, ethanol or combinations thereof.

4. The device according to claim 1 , wherein said anti-abuse substance includes an amount of an irritant.

5. The device according to claim 1 , wherein said anti-abuse substance includes an amount of an antagonist.

6. The device according to claim 1 , wherein said container is in the form of a flexible pouch.

7. The device according to claim 1 , wherein said closure device includes an adhesive seal.

8. The device according to claim 1 , wherein said abusable substance is an opioid.

9. The device according to claim 8 , wherein said abusable substance is fentanyl.

10. The device according to claim 1 , wherein said closure means comprises a zip lock seal.

11. The device according to claim 1 , wherein said layer containing an amount of an anti-abuse substance is attached to one side of said container.

12. The device according to claim 1 , wherein said closure means comprises an adhesive strip on each side of said opening of said container.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2016
From: TEIKOKU PHARMA USA, INC.
To: VERDE ENVIRONMENTAL TECHNOLOGIES, INC.
Reel/Frame 039563/0875 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2011
From: TRAVANTI PHARMA INC.
To: TEIKOKU PHARMA USA, INC.
Reel/Frame 026435/0494 →
CHANGE OF NAME Recorded Jan 10, 2011
From: BIRCH POINT MEDICAL, INC.
To: TRAVANTI PHARMA INC.
Reel/Frame 025613/0308 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2010
From: ANDERSON, CARTER R.; MORRIS, RUSSELL L.
To: BIRCH POINT MEDICAL
Reel/Frame 025382/0012 →